Moreover, treatment of APP/PS1 mice with antibodies against Aβ3-Xpyro-E3 ameliorates behavioral symptoms and decreases amyloid plaque numbers, which is likely due to FcR-mediated clearance by microglia [161]. Here, APP is linked to amyloidosis.